CompuGroup Medical SE & Co. KGaA
CompuGroup Medical SE & Co. KGaA (CMPUY) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
cmpuy · pe ratio · data through Dec 31, 2024
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for CompuGroup Medical SE & Co. KGaA (CMPUY) measures how much investors pay for each dollar of the company's trailing earnings. CMPUY's current PE ratio of 263.62x is calculated by dividing its stock price of $23.00 by its TTM earnings per share of $0.09. +557.6% elevated vs 5Y avg 40.1x
Source: FMP · /ratios-ttm · /analyst-estimates · 2024-12-31
PE Ratio History
2006 – 2024 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
Historical PE Range
Past 19 fiscal years · Front-end computedMinQ1 · 25%35.0x
MedianQ3 · 75%593.5x
Max
At 263.62x, CMPUY's current P/E is higher than in 95% of its annual fiscal year readings over the past 19 years — historically elevated.
Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.
PE Ratio vs Peers
Medical - Healthcare Information Services · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
CompuGroup Medical SE & Co. KGaAYou CMPUY | $1.2B | 263.62x | +563.7% | $0.09 |
 Biotage AB (publ) BITGF | $1.2B | 46.23x | +16.4% | $3.55 |
 Biotest AG BTTAY | $943M | 66.05x | +66.3% | $0.35 |
 China Shineway Pharmaceutical Group Limited CSWYF | $816M | 5.56x | -86.0% | $1.26 |
 Drägerwerk AG & Co. KGaA DGWPF | $1.4B | 8.23x | -79.3% | $7.44 |
 Drägerwerk AG & Co. KGaA DWRKF | $1.8B | N/A | — | — |
 Kaken Pharmaceutical Co., Ltd. KKPCF | $1.0B | 72.51x | +82.6% | $56.91 |
Industry Average 5 peers with valid PE | — | 39.72x | baseline | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2024-12-31Latest FY2024 | 33.34x | $0.67 | -21.5% | |
2023-12-31 FY2023 | 42.48x | $0.88 | +58.8% | |
2022-12-31 FY2022 | 26.75x | $1.41 | -47.3% | |
2021-12-31 FY2021 | 50.71x | $1.32 | +7.5% | |
2020-12-31 FY2020 | 47.15x | $1.36 | +144.5% | |
2019-12-31 FY2019 | 19.28x | $1.36 | +41.1% | |
2018-12-31 FY2018 | 13.66x | $1.88 | -64.9% | |
2017-12-31 FY2017 | 38.97x | $0.63 | +25.0% | |
2016-12-31 FY2016 | 31.17x | $0.90 | -10.9% | |
2015-12-31 FY2015 | 34.97x | $0.77 | +0.7% |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for CompuGroup Medical SE & Co. KGaA (CMPUY) measures how much investors pay for each dollar of the company's trailing earnings. CMPUY's current PE ratio of 263.62x is calculated by dividing its stock price of $23.00 by its TTM earnings per share of $0.09.
Frequently asked questions
CMPUY pe ratio · 6 questionsCMPUY's current PE ratio is 263.62x as of 2026-06-08, based on a stock price of $23.00 and TTM EPS of $0.09. Data sourced from Financial Modeling Prep via CMPUY's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · CompuGroup Medical SE & Co. KGaA SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08